Fat tissue sends a signal to the brain that strengthens muscle
In the long human search for ways to age with strength and dignity, Japanese researchers may have found an unlikely ally in a centuries-old kitchen staple. A bioactive compound in aged garlic extract, known as S1PC, appears to slow the erosion of muscle strength in older adults—not by acting on muscle directly, but by orchestrating a quiet conversation between fat tissue, brain, and body. Published in Cell Metabolism and tested across cells, animals, and humans, the finding invites us to reconsider how deeply interconnected our organs are, and how ancient remedies might yet yield modern medicine.
- Muscle frailty in aging populations is straining healthcare systems worldwide, and existing treatments are costly, hard to sustain, and often lack rigorous scientific support.
- S1PC disrupts assumptions about how the body regulates strength—it bypasses muscle entirely, signaling fat tissue to release a protein that travels to the brain and amplifies the nervous system's energy response.
- Animal trials showed measurable reductions in frailty markers and restored muscle strength, while a parallel human study confirmed the compound safely raises circulating levels of the key protein eNAMPT.
- Researchers caution that larger, longer human trials are still needed before S1PC can be recommended as a therapeutic supplement, and several questions about its full mechanism remain open.
- The compound's centuries of safe traditional use in aged garlic gives it a head start in safety credibility, positioning it as a plausible complement to other emerging anti-aging approaches.
Japanese researchers have identified a compound in aged garlic extract—called S1PC—that may help preserve muscle strength in older adults through a surprisingly indirect route. Rather than acting on muscle tissue directly, S1PC triggers a cascade that begins in fat tissue and ends in the brain. The study, published in Cell Metabolism, emerged from a collaboration between Tokyo's Institute for Productive Aging Research and Hiroshima-based Wakunaga Pharmaceutical.
The mechanism is intricate: S1PC activates an enzyme called LKB1, which sets off a chain reaction activating the SIRT1 pathway. This prompts fat tissue to release a protein called eNAMPT into the bloodstream, which travels to the hypothalamus and amplifies signals from the sympathetic nervous system—ultimately improving muscle function. The discovery maps a previously unknown dialogue between fat, brain, and muscle.
In aging mice, long-term S1PC administration reduced frailty markers, increased muscle strength, and restored core body temperature. A parallel human study confirmed that the compound raises eNAMPT circulation levels, particularly in individuals with sufficient fat tissue. The consistency of results across biological scales suggests the mechanism is robust.
Lead author Dr. Kiyoshi Yoshioka, a physical therapist by training, described his motivation as clinical frustration—watching older patients lose vitality without a specific disease to treat. He envisions S1PC as a simple daily supplement to help people maintain strength. Co-investigator Dr. Shin-ichiro Imai suggested the compound's effects may extend beyond muscle, warranting broader investigation.
Aged garlic's centuries of safe traditional use gives S1PC a favorable starting point for safety evaluation. Still, researchers emphasize that larger and longer human trials are essential before the compound can be widely recommended, and questions about LKB1's potential role in the brain itself remain unanswered. The path from promising discovery to proven therapy is not short—but the early signals are compelling enough to justify the journey.
Japanese researchers have identified a compound in aged garlic extract that appears to slow the loss of muscle strength that comes with age. The compound, called S1PC, works through an unexpected route: it doesn't act on muscle directly. Instead, it sends a signal to fat tissue, which then communicates with the brain in a way that ultimately strengthens muscles. The finding, published in Cell Metabolism, comes from a collaboration between Tokyo's Institute for Productive Aging Research and Wakunaga Pharmaceutical, a company based in Hiroshima that specializes in aged garlic products.
Muscle weakness in older adults has become a growing public health concern as populations age worldwide. The condition, sometimes called frailty, drains resources from healthcare systems and diminishes quality of life. Existing pharmaceutical treatments are expensive and difficult to sustain long-term. Dietary interventions exist, but most lack rigorous scientific backing. This gap motivated the research team to investigate compounds found in aged garlic extract—a substance used in traditional medicine for generations—to see if any could be developed into evidence-based anti-aging interventions.
The mechanism S1PC activates is intricate. The compound triggers an enzyme called LKB1, which sits at a crossroads of cellular metabolism. This activation sets off a chain reaction: a protein complex forms, which switches on a pathway known as SIRT1. This pathway tells fat tissue to release a protein called eNAMPT into the bloodstream, packaged inside tiny vesicles. The eNAMPT travels through circulation to the hypothalamus, a control center deep in the brain. There it amplifies signals from the sympathetic nervous system—the body's accelerator for alertness and energy. The result is improved muscle function. The discovery reveals a previously unknown conversation between three organs: fat tissue, brain, and muscle.
When researchers tested S1PC in aging mice, the results were measurable. Long-term administration reduced markers of frailty, increased muscle strength, and restored core body temperature. A parallel human study showed that S1PC raised circulating levels of eNAMPT, particularly in people with adequate fat tissue. The fact that this effect held true across cells, animals, and humans suggests the mechanism is robust enough to translate into a human therapy.
Dr. Kiyoshi Yoshioka, one of the study's lead authors, described his motivation in clinical terms. As a physical therapist, he had grown frustrated watching older adults lose function and vitality without any specific disease to treat—a gap in preventive care. He hopes the findings will help people maintain strength and fitness simply by adding a daily supplement to their diet. Dr. Shin-ichiro Imai, who leads the institute, emphasized that S1PC may have broader anti-aging effects beyond muscle preservation, warranting deeper investigation.
Aged garlic extract carries a significant advantage: it has been consumed safely for centuries in traditional medicine with no reported adverse effects. This long history of use suggests S1PC would have a favorable safety profile. The compound could complement other emerging approaches, such as therapies that boost NAD+, a molecule central to cellular energy and repair. However, researchers stress that more work remains. They need to confirm that S1PC improves muscle function in larger human populations, measure its effects over years rather than weeks, and explore whether LKB1 plays a role in the brain itself. The pathway from laboratory discovery to daily supplement is not automatic, but the early signals are encouraging enough to justify the next phase of research.
Notable Quotes
During my clinical experience as a physical therapist, I was often frustrated seeing older adults lose physical function and vitality simply because they had no specific disease requiring medical treatment. This gap in preventive care drove my research.— Dr. Kiyoshi Yoshioka, lead researcher
Our findings reveal a unique and previously unknown function of S1PC in activating LKB1 and promoting cross-organ communication that reduces muscle frailty.— Dr. Shin-ichiro Imai, Institute director
The Hearth Conversation Another angle on the story
Why does the compound work through fat tissue instead of directly on muscle? That seems like an odd detour.
It's not a detour—it's a conversation. The brain needs to know what's happening in the body. Fat tissue acts as a messenger, releasing eNAMPT when S1PC tells it to. The brain picks up that signal and adjusts the nervous system accordingly. Direct action on muscle would be simpler, but this cross-organ communication might be why it works so well.
So the brain is essentially being told to keep the muscles strong?
More like the brain is being reminded that the muscles matter. With age, that signaling gets quieter. S1PC turns up the volume on the sympathetic nervous system—the part that says "stay alert, stay ready." Stronger muscles follow.
The mice got stronger. Will humans?
That's the honest question. The mice results are clear. The human data so far shows the mechanism works—eNAMPT levels rise. But we haven't yet proven that translates to measurable strength gains in people over time. That's the next study.
Why aged garlic specifically? Why not just synthesize S1PC?
You could synthesize it, but aged garlic has been used safely for centuries. If you're going to ask people to take something daily, that history matters. It's not just about the compound—it's about trust and safety.
What happens if someone doesn't have much fat tissue?
That's a real limitation. The mechanism depends on fat tissue releasing the messenger. Very lean older adults might not benefit as much. The researchers noted that effect in their human data. It's a reminder that biology isn't one-size-fits-all.